Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.77
- Piotroski Score 4.00
- Grade Neutral
- Symbol (CYRX)
- Company Cryoport, Inc.
- Price $6.60
- Changes Percentage (-1.57%)
- Change -$0.11
- Day Low $6.48
- Day High $6.73
- Year High $20.11
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $16.50
- High Stock Price Target $52.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.48
- Trailing P/E Ratio -4.48
- Forward P/E Ratio -4.48
- P/E Growth -4.48
- Net Income $-99,587,000
Income Statement
Quarterly
Annual
Latest News of CYRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Should You Hold Cryoport (CYRX)?
Brown Capital Management's Small Company Fund underperformed in Q2 2024, returning -6.57% compared to the Russell 2000 Growth index. The fund focuses on Exceptional Growth Companies, such as Cryoport,...
By Yahoo! Finance | 2 months ago -
Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)?
Conestoga Capital Advisors' Q2 2024 investor letter discusses market moderation. Their Micro-Cap Strategy declined 8.52%, with underperformance in sectors like Telecommunications and Health Care. Cryo...
By Yahoo! Finance | 3 months ago -
Shareholders in Cryoport (NASDAQ:CYRX) are in the red if they invested three years ago
Cryoport, Inc. (NASDAQ: CYRX) stock rose by 31% this month after facing an 85% drop over three years. Investors should consider if the business has truly turned around. Focus on revenue growth as the ...
By Yahoo! Finance | 3 months ago